SEB Asset Management’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.3M Hold
228,093
– – 0.03% 390
2026
Q2
$8.83M Buy
228,093
+63,656
+39% +$2.23M 0.03% 364
2026
Q1
$6.33M Buy
+164,437
New +$6.07M 0.03% 412

Other funds holding COGT

SEB Asset Management's COGT Position: Q3 2026 in Review

SEB Asset Management held its Cogent Biosciences (COGT) position steady in Q3 2026 at 228,093 shares worth $7.3M. The position accounts for 0.03% of the portfolio, ranked #390.

SEB Asset Management first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.83M in Q2 2026. 314 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • SEB Asset Management held 228,093 shares of Cogent Biosciences worth $7.3M as of Q3 2026.
  • SEB Asset Management left its Cogent Biosciences share count unchanged in Q3 2026.
  • Cogent Biosciences made up 0.03% of SEB Asset Management's portfolio in Q3 2026, its #390 holding.
  • SEB Asset Management first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's Cogent Biosciences position peaked at $8.83M in Q2 2026.
  • 314 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.